Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tributes have begun pouring in across the University of Oxford and the international neuroscience and psychology communities today in response to the news that Professor Glyn Humphreys passed away suddenly yesterday morning. Professor Humphreys was Watts Professor of Experimental Psychology and Head of the Department of Experimental Psychology at the University of Oxford. He was a leading light of cognitive neuropsychology and received the British Psychological Society Lifetime Achievement Award in 2015 in recognition of his exceptional contributions to the field of psychology.

Responding to the news, Professor Alastair Buchan, Head of the Medical Sciences Division, said in a statement this morning: ‘I speak for the whole Division when I say we are all affected by this extremely sad news. Glyn was so young and so full of life and vitality. Together with his wife and colleague Jane Riddoch they brought both wisdom and experience to both Experimental Psychology and the John Radcliffe Hospital. He is going to be terribly missed. Our thoughts are with his wife Jane and their family.’

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.